| Evan Chafitz Dmd Pc | |
|
1075 Central Park Ave Suite 207 Scarsdale NY 10583-3242 | |
| (914) 472-5252 | |
| (914) 722-5987 |
| Full Name | Evan Chafitz Dmd Pc |
|---|---|
| Speciality | Dentist |
| Location | 1075 Central Park Ave, Scarsdale, New York |
| Authorized Official Name and Position | Erica Quinteros (CREDENTIALING) |
| Authorized Official Contact | 7249011964 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Evan Chafitz Dmd Pc 1075 Central Park Ave Suite 207 Scarsdale NY 10583-3242 Ph: (914) 472-5252 | Evan Chafitz Dmd Pc 1075 Central Park Ave Suite 207 Scarsdale NY 10583-3242 Ph: (914) 472-5252 |
| NPI Number | 1700032562 |
|---|---|
| Provider Enumeration Date | 08/13/2008 |
| Last Update Date | 10/10/2023 |
| Medicare PECOS PAC ID | 8022394261 |
|---|---|
| Medicare Enrollment ID | O20170424001538 |
News Archive
From gold medalists to weekend warriors, athletes at every level are in search of new ways to reduce pain and enhance post-exercise recovery. Recent research shows that drinking tart cherry juice may help runners recover more quickly and effectively from post-race pain.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
A new study conducted at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA discovered how increased glucose levels caused either by diabetes or other factors keep heart cells from maturing normally.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700032562 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223S0112X | Dentist - Oral And Maxillofacial Surgery | 043847 (New York) | Primary |
| Provider Name | Evan Chafitz |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1760549505 PECOS PAC ID: 3779541586 Enrollment ID: I20041227000687 |
News Archive
From gold medalists to weekend warriors, athletes at every level are in search of new ways to reduce pain and enhance post-exercise recovery. Recent research shows that drinking tart cherry juice may help runners recover more quickly and effectively from post-race pain.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
A new study conducted at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA discovered how increased glucose levels caused either by diabetes or other factors keep heart cells from maturing normally.
› Verified 5 days ago
| Provider Name | Mckinley Lenard Price |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1164679791 PECOS PAC ID: 9032333059 Enrollment ID: I20140613001145 |
News Archive
From gold medalists to weekend warriors, athletes at every level are in search of new ways to reduce pain and enhance post-exercise recovery. Recent research shows that drinking tart cherry juice may help runners recover more quickly and effectively from post-race pain.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
A new study conducted at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA discovered how increased glucose levels caused either by diabetes or other factors keep heart cells from maturing normally.
› Verified 5 days ago
| Provider Name | Heather Zanon Fugazy |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1366829053 PECOS PAC ID: 7719355320 Enrollment ID: I20221201000717 |
News Archive
From gold medalists to weekend warriors, athletes at every level are in search of new ways to reduce pain and enhance post-exercise recovery. Recent research shows that drinking tart cherry juice may help runners recover more quickly and effectively from post-race pain.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
A new study conducted at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA discovered how increased glucose levels caused either by diabetes or other factors keep heart cells from maturing normally.
› Verified 5 days ago
| Provider Name | Matthew Frank Lalli |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1659635175 PECOS PAC ID: 9335518166 Enrollment ID: I20221216001701 |
News Archive
From gold medalists to weekend warriors, athletes at every level are in search of new ways to reduce pain and enhance post-exercise recovery. Recent research shows that drinking tart cherry juice may help runners recover more quickly and effectively from post-race pain.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
A new study conducted at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA discovered how increased glucose levels caused either by diabetes or other factors keep heart cells from maturing normally.
› Verified 5 days ago
| Provider Name | Kristen Ariel Rogers |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1033831821 PECOS PAC ID: 2365811163 Enrollment ID: I20221219001466 |
News Archive
From gold medalists to weekend warriors, athletes at every level are in search of new ways to reduce pain and enhance post-exercise recovery. Recent research shows that drinking tart cherry juice may help runners recover more quickly and effectively from post-race pain.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
A new study conducted at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA discovered how increased glucose levels caused either by diabetes or other factors keep heart cells from maturing normally.
› Verified 5 days ago
| Provider Name | Mia D Kutner |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1548720873 PECOS PAC ID: 8820326481 Enrollment ID: I20230905000450 |
News Archive
From gold medalists to weekend warriors, athletes at every level are in search of new ways to reduce pain and enhance post-exercise recovery. Recent research shows that drinking tart cherry juice may help runners recover more quickly and effectively from post-race pain.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
A new study conducted at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA discovered how increased glucose levels caused either by diabetes or other factors keep heart cells from maturing normally.
› Verified 5 days ago
| Provider Name | Jason Lee |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1205398021 PECOS PAC ID: 1557718178 Enrollment ID: I20231103000586 |
News Archive
From gold medalists to weekend warriors, athletes at every level are in search of new ways to reduce pain and enhance post-exercise recovery. Recent research shows that drinking tart cherry juice may help runners recover more quickly and effectively from post-race pain.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
A new study conducted at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA discovered how increased glucose levels caused either by diabetes or other factors keep heart cells from maturing normally.
› Verified 5 days ago
News Archive
From gold medalists to weekend warriors, athletes at every level are in search of new ways to reduce pain and enhance post-exercise recovery. Recent research shows that drinking tart cherry juice may help runners recover more quickly and effectively from post-race pain.
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to "develop very thin, flexible, injectable microstimulators to restore movement in paralysis", says Ivorra, principal investigator of the project.
Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.
A team of researchers recently demonstrated that mutations in the S protein of SARS-CoV-2 select for amino acid changes that result in a more stable protein than would otherwise be expected.
A new study conducted at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA discovered how increased glucose levels caused either by diabetes or other factors keep heart cells from maturing normally.
› Verified 5 days ago
Scarsdale Dental Group Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 14 Harwood Ct., Ste 211, Scarsdale, NY 10583 Phone: 914-723-4707 Fax: 914-723-6209 | |
Smiles By Mariah Dentistry Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 188 Summerfield St, Scarsdale, NY 10583 Phone: 914-472-2929 | |
Dental Arts Of Scarsdale, Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 75 Brook St, Scarsdale, NY 10583 Phone: 914-722-0111 Fax: 914-722-6052 | |
Sidney M. Rosen, D.d.s., P.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 455 Central Park Avenue, Suite 309, Scarsdale, NY 10583 Phone: 914-725-5700 Fax: 914-725-6340 | |
New York Dental Service Providers, Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 777 White Plains Rd, Scarsdale, NY 10583 Phone: 914-472-9090 | |
Scarsdale Family Cosmetic Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1075 Central Park Ave, Suite #104, Scarsdale, NY 10583 Phone: 914-472-9400 | |
Tongue-tie Dental Of Ny Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 774 White Plains Rd # 205, Scarsdale, NY 10583 Phone: 204-724-7744 Fax: 203-286-1203 |